compound · derived
Osimertinib
2 trials · 0 approvals
| Trials | 2 |
|---|---|
| Approvals | 0 |
| Phases | Phase 2 |
Provenance
- Source: Derived from ClinicalTrials.gov and openFDA
- Fetched at: 2026-10-28T13:38:09.116Z
- Licence class: internal-only
- Verdict: derived
- Entity id: osimertinib
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- osimertinib · trial
- Osimertinib · trial